Joel Handler
Joel Handler
A young hypertensive woman with a rare diagnosis of middle aortic syndrome [0.03%]
年轻高血压女性中空腹主动脉综合征的罕见病例
Nimit C Shah
Nimit C Shah
Cardiovascular risks of dipping status and chronic kidney disease in elderly Japanese hypertensive patients [0.03%]
老年日本高血压患者昼夜血压节律异常与慢性肾脏病的血管风险及其关联性分析
Joji Ishikawa,Motohiro Shimizu,Satoshi Hoshide et al.
Joji Ishikawa et al.
Chronic kidney disease (CKD) increases the risk of cardiovascular events and is often associated with the nondipping pattern of blood pressure (BP). We evaluated ambulatory BP, CKD, and the incidence of cardiovascular events in 811 older hy...
Sex differences in the hypertensive population with chronic ischemic heart disease [0.03%]
慢性缺血性心脏病高血压患者的性别差异
Vivencio Barrios,Carlos Escobar,Vicente Bertomeu et al.
Vivencio Barrios et al.
Cardiopatía Isquémica Crónica e Hipertensión Arterial en la Práctica Clínica en España (CINHTIA) was a survey designed to assess the clinical management of hypertensive outpatients with chronic ischemic heart disease. Sex differences...
National utilization of antihypertensive medications from 2000 to 2006 in the Veterans Health Administration: focus on thiazide diuretics [0.03%]
美国退伍军人卫生管理局2000～2006年全国抗高血压药物应用情况：噻嗪类利尿剂为重点
Elaine M Furmaga,Francesca E Cunningham,William C Cushman et al.
Elaine M Furmaga et al.
The authors sought to determine the prescribing practices of clinicians treating veterans with hypertension. A descriptive analysis was performed using a national pharmacy database of patients with a diagnosis of hypertension receiving anti...
Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy [0.03%]
钙拮抗剂对糖尿病肾病患者蛋白尿的影响
Robert D Toto,Min Tian,Kaffa Fakouhi et al.
Robert D Toto et al.
Diabetic nephropathy management should include the use of an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker with additional antihypertensive medications to reduce proteinuria and cardiovascular events. Som...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2008 Oct;10(10):761-9. DOI:10.1111/j.1751-7176.2008.00016.x 2008
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [0.03%]
抗高血压及降脂治疗以预防心肌梗死试验(ALLHAT)中各类药物对血压控制的作用
William C Cushman,Charles E Ford,Paula T Einhorn et al.
William C Cushman et al.
Blood pressure (BP) control rates and number of antihypertensive medications were compared (average follow-up, 4.9 years) by randomized groups: chlorthalidone, 12.5-25 mg/d (n=15,255), amlodipine 2.5-10 mg/d (n=9048), or lisinopril 10-40 mg...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2008 Oct;10(10):751-60. DOI:10.1111/j.1751-7176.2008.00015.x 2008
Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years [0.03%]
坎地沙坦治疗6至17岁高血压儿童的疗效、安全性和药代动力学研究
Howard Trachtman,James W Hainer,Jennifer Sugg et al.
Howard Trachtman et al.
This 4-week randomized, double blind, placebo-controlled study (N=240), 1-year open label trial (N=233), and single-dose pharmacokinetic study (N=22) evaluated candesartan cilexetil (3 doses) in hypertensive children aged 6 to 17 years. Sev...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2008 Oct;10(10):743-50. DOI:10.1111/j.1751-7176.2008.00022.x 2008
Norman M Kaplan
Norman M Kaplan
Michael J Bloch,Jan N Basile
Michael J Bloch